Johnson & Johnson announced that it is selling its Cordis business, which makes vascular technology, to Cardinal Health for approximately $1.94 billion. Cardinal will acquire Cordis for an aggregate value of $1.99 billion, consisting of $1.944 billion of cash proceeds plus approximately $46 million of retained net receivables. Cordis is …